Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Bravo Medicine AB
AB
Active
Org 5594181322
Liljeörnsgatan 33
General medical practice activities · NACE 8621
Est. 2023
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 1,5M
+6% vs 2023
EBITDA margin
28.7%
-42% vs 2023
Equity ratio
53.0%
Financial strength
Net profit 2024
SEK 311K
-46% vs 2023
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
1M
2023
0M
-100%
2024
Key figures
Annual report 2024
Revenue
SEK 1,5M
+6%
EBITDA
SEK 427K
-42%
Net profit
SEK 311K
-46%
Total assets
SEK 1,3M
+18%
Equity
SEK 712K
+18%
Employees
0
—
Company information
Legal name
Bravo Medicine AB
Org number
5594181322
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
16 januari 2023
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska bedriva konsultverksamhet inom vård och omsorg.
Contact
Address
Liljeörnsgatan 33
Email
arthur.g.bravo@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2023
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2023
0M
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
1 400
1 489
Staff expenses
—
−882
EBITDA
741
427
Depreciation & amort.
−9
−37
EBIT
732
390
Net financials
−1
3
Profit before tax
731
393
Tax
−151
−82
Net profit
580
311
Balance sheet
SEK thousands
Item
2023
2024
Total assets
1 136
1 343
Equity
605
712
Long-term debt
14
10
Short-term debt
516
622
Total debt
530
631
Financial ratios
5-year trend
EBITDA margin
28.7%
This company
15.8%
Market median
+82% vs market
2023
2024
Equity ratio
53.0%
This company
38.2%
Market median
+39% vs market
2023
2024
Return on equity
43.7%
This company
18.4%
Market median
+138% vs market
2023
2024
Net profit margin
20.9%
This company
8.1%
Market median
+158% vs market
2023
2024
Asset turnover
1.11×
This company
1.12×
Market median
+1% vs market
2023
2024
Debt / equity
0.89×
This company
0.62×
Market median
+44% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
JB
Jose-Issa Bravo
Deputy Board Member
2023
AG
Arthur Gottschalk Bravo
Board of Directors
2023
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Bravo Medicine AB also hold positions in
0
other companies.
Person
Role here
Other companies
Jose-Issa Bravo
Deputy Board Member
0 companies
Arthur Gottschalk Bravo
Board of Directors
0 companies